• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Impact of the second and third COVID-19 waves on out patient malaria indicators and case management guidelines at selected sites with varying malaria transmission intensities in Uganda.

    Thumbnail
    View/Open
    Master's dissertation (1.126Mb)
    Date
    2023-01-20
    Author
    Mukisa, Pius
    Metadata
    Show full item record
    Abstract
    Background: COVID-19 has imposed negative impacts on the fight against malaria in many malaria endemic countries. We aimed to assess the impact of the second and third COVID-19 waves on outpatient malaria indicators and adherence to malaria case management practices at selected sites of varying malaria transmission intensities in Uganda. Methods: A time trend ecological study was conducted using existing data at three public health facilities including: 1) Lumino HC III; 2) Walukuba HC IV; 3) Kasambya HCIII. Records of all patients who reported to the outpatient departments of the selected facilities between January 2019 and February 2022 were retrieved and extracted. Using pre-COVID 19 trends (January 2019-February 2020), interrupted time series analysis was used to predict the expected trends for the study outcomes during the 2nd (March 2021-October 2021) and 3rd (November 2021-February 2022) COVID-19 waves. Results: The observed average outpatient department attendance during the 2nd COVID-19 wave was significantly lower compared to what was expected (3916 vs 4888; incidence rate ratio(IRR)= 0.80 [0.67-0.93]). There were no differences between the observed versus expected proportion of suspected malaria cases (34.87% vs 34.93%; relative percent ratio(RPR) =0.99[0.93-1.06]). The observed overall test positivity rate was lower than what was expected/predicted (35.57% vs 45.39%; RPR=0.78 [0.72-0.85]). The observed OPD attendance in the third wave had similar trends to what was seen in the 2nd wave. The observed proportion of suspected malaria cases in the third wave had similar trends to what was seen in the 2nd wave. The observed overall TPR in the 3rd wave had similar trends to what was seen in the 2nd wave. There were no differences in observed versus expected proportion of tested malaria and confirmed cases prescribed AL in both waves.
    URI
    http://hdl.handle.net/10570/11667
    Collections
    • School of Medicine (Sch. of Med.) Collections

    Related items

    Showing items related by title, author, creator and subject.

    • Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda 

      Bakyaita, Nathan; Dorsey, Grant; Adoke, Yeka; Banek, Kristin; Staedke, Sarah G.; Kamya, Moses R.; Talisuna, Ambrose; Kironde, Fred; Nsobya, Sam; Kilian, Albert; Reingold, Arthur; Rosenthal, Philip J.; Wabwire-Mangen, Fred (2005)
      The use of combinations of inexpensive drugs for the treatment of malaria in Africa has been proposed as an interim policy while awaiting the widespread availability of more effective regimens. We compared sulfadoxinepyrimethamine ...
    • Genetic polymorphisms in plasmodium falciparum associated with resistance to artemisinin combination therapy: complexity of infection during short-term culture and characterization of in vitro sensitivity in Kampala Uganda 

      Nsobya, Samuel Lubwama (Makerere University, 2010)
      Background: Artemisinin-based combination therapy (ACT) is currently advocated in Africa as a means of improving treatment efficacy and slowing the development of drug resistance. However, the selection of resistant ...
    • Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda 

      Yeka, Adoke; Kamya, Moses R.; Dorsey, Grant; Talisuna, Ambrose; Lugemwa, Myers; Rwakimari, John Bosco; Staedke, Sarah G.; Rosenthal, Philip J.; Wabwire-Mangen, Fred; Bukirwa, Hasifa (Public Library of Science, 2008-06)
      Background: Uganda recently adopted artemether-lumefantrine (AL) as the recommended first-line treatment for uncomplicated malaria. However, AL has several limitations, including a twice-daily dosing regimen, recommendation ...

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV